Puma Biotechnology, Inc.
PBYI · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $228M | $230M | −0.9% |
| Operating income | $37.3M | $31.0M | +20.4% |
| Net income | $31.1M | $30.3M | +2.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $55.1M | $54.5M | +1.1% |
| Operating income | $5.30M | $9.60M | −44.8% |
| Net income | $6.00M | $8.80M | −31.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Puma Biotechnology's revenue in FY2025?
- $228M in FY2025 (Fiscal year ended Dec 31, 2025), −0.9% vs $230M a year earlier, per its 10-K filed Feb 2026.
- Was Puma Biotechnology profitable in FY2025?
- Yes: net income was $31.1M and operating income $37.3M in FY2025.
- What was Puma Biotechnology's revenue in Q3 2026?
- $55.1M (+1.1% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.